Impact of Fever Prevention in Brain Injured Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 686 participants.
Also called NCT02996266
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 686 participants
- Sponsor
- Registry
-
NCT02996266
-
- Other papers using this trial's data
- Fever Prevention in Patients With Acute Vascular Brain Injury: The INTREPID Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Germany, South Korea, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT02996266. Randomized; single masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2022-05-12 (actual). Results posted on 2023-09-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Fever Prevention in Brain Injured Patients
- Acronym
- INTREPID
- Condition
- Fever
- Condition
- Ischemic Stroke
- Condition
- Intracerebral Hemorrhage
- Condition
- Subarachnoid Hemorrhage
- Intervention (Device)
- Targeted Temperature Management
- Intervention (Other)
- Standard Care
- Lead sponsor
- C. R. Bard
- Collaborator
- Yale University
- Collaborator
- Boston University
Record details
- Record id
cardio:ct-nct02996266- Content hash
56ecb49bb87b3e96695452fa4b6334ad46ae16835e3e758763ec1f192127aabf